⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DBVT News
DBV Technologies S.A.
Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight
prnewswire.com
DBVT
NVS
AQST
GSK
REGN
DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales
globenewswire.com
DBVT
Form 8-K
sec.gov
DBVTF
DBVT
DBV Technologies Announces the Filing of its 2026 Half-Year Report ― Conditions for Accessing or Consulting the Report
globenewswire.com
DBVT
DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update
globenewswire.com
DBVT
DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026
globenewswire.com
DBVT
Form 8-K
sec.gov
DBVT
DBVTF
DBV Technologies révise sa participation à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs
globenewswire.com
DBVT
Form 8-K
sec.gov
DBVTF
DBVT
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
globenewswire.com
DBVT